Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms, Plasma Cell 3Multiple Myeloma 3Leukemia 2Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1Carcinoma, Basal Cell 1Breast Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 6fludarabine phosphate 4Radiotherapy 3Mycophenolic Acid 3Cyclosporine 3Whole-Body Irradiation 2Therapeutics 2Tacrolimus 2Pentetic Acid 2Methotrexate 2Cyclophosphamide 2Busulfan 2ethanolamine oleate 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Transplantation 1Thiotepa 1Sulfamethoxazole 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Psychiatric Rehabilitation 1Pentostatin 1Minocycline 1Melphalan 1Insulin Glargine 1Insulin 1In Situ Hybridization, Fluorescence 1Immunoenzyme Techniques 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Congenital Abnormalities × Arsenic Trioxide × Clear all
NCT01835288 2018-05-21

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Stanford University

Phase 2 Withdrawn
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡